Host-response in gastric mucosa in fected with Helicobacter pylori

幽门螺杆菌感染胃粘膜的宿主反应

基本信息

  • 批准号:
    14571187
  • 负责人:
  • 金额:
    $ 2.24万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2002
  • 资助国家:
    日本
  • 起止时间:
    2002 至 2003
  • 项目状态:
    已结题

项目摘要

Our experiments revealed the followings :1.The animal model of duodeno-gastric reflux (DGR) was established using Mongolian gerbils (MGs). The DGR accelerated the turnover of gastric epithelial cells, although it decreased the activity of HP-induced gastritis in the early phase of the gastritis. The alterations of bacterial flora in stomach caused the DGR.2.a4GnT is a key-enzyme to regulate the production of glandular mucous mucin. mRNA-expression of a4GnT, IL-1B, TNFa, IL-4,IL 6 and IL-10 were quantified at some points after inoculation of HP in MGs. Results : (1)mRNA-expression of a4GnT increased at early phase of HP-induced gastritis. (2)IL-1B and TNFa showed same response as a4GnT. (3)IL-4,6 and 10 increased at the late phase of HP-induced gastritis. Immune response of the gastric mucosa changed with time from Th1-to Th2-dominant. (4)Thick mucoid-caps of glandular mucous mucin were formed at mucosal surface of the stomach infected with HP.3.The extract essence of rice inhibits HP-induced gastritis.4.The expression of cytokines (both Th1 and Th2) increased in MGs that were treated with HP and nitroso-compounds. MG is a useful animal model to investigate the relationship among HP-infection, host-response and environmental factors.
本实验主要研究内容如下:1.建立了蒙古沙鼠十二指肠胃反流(DGR)动物模型。DGR虽然在胃炎的早期阶段降低了HP诱导的胃炎的活动性,但促进了胃上皮细胞的更新。胃内细菌植物群的改变引起胃内胃粘膜的变化。2.a4 GnT是调节胃粘膜粘液生成的关键酶。在MG中接种HP后的某些时间点定量α 4 GnT、IL-1B、TNF α、IL-4、IL-6和IL-10的mRNA表达。结果:(1)a4 GnT mRNA在HP诱导的胃炎早期表达增加。(2)IL-1B和TNF α与α 4 GnT反应相同。(3)IL-4、IL-6、IL-10在HP诱导的胃炎晚期升高。胃粘膜的免疫应答随时间由Th 1-为主向Th 2-为主变化。(4)HP感染胃粘膜表面形成厚的粘液样帽;(3)米精对HP诱导的胃炎有抑制作用;(4)HP和亚硝基化合物处理的MG中Th 1和Th 2细胞因子的表达增加。MG是研究HP感染、宿主反应和环境因素之间关系的理想动物模型。

项目成果

期刊论文数量(52)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Gotoh A, Akamatsu T, Sugiyama A: "Addititive effect of pronase on the efficacy of eradication therapy against Helicobacter pylori"Helicobacter. 7巻. 183-191 (2002)
Gotoh A、Akamatsu T、Sugiyama A:“链霉蛋白酶对幽门螺杆菌根除治疗效果的累加效应”Helicobacter. Vol. 7. 183-191 (2002)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Shimizu F, Sugiyama A et al.: "Usefulness of the Real-Time Reverse Transcription-Polymerase Chain Reaction to α1,4-N-Acetylglucosaminyltransferase for the Detection of Gastric Cancer"Laboratory Investigation. 83巻. 187-197 (2003)
Shimizu F、Sugiyama A 等人:“α1,4-N-乙酰葡糖胺基转移酶的实时逆转录聚合酶链反应在检测胃癌中的用途”实验室研究,第 83 卷,187-197。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Nozaki K, Sugiyama A et al.: "Reversibility of Heterotopic Proliferative Glands in Glandular Stomach of Helicobacter pylori-infected Mongolian Gerbils on Eradication"Jap. J Cancer Res. 93巻. 374-381 (2002)
Nozaki K,Sugiyama A 等:“根除幽门螺杆菌感染的蒙古沙鼠腺胃中异位增殖腺的可逆性”Jap. J Cancer Res. 93. 374-381 (2002)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Nozaki K, Shimizu N, Tsukamoto T, Sugiyama A et al.: "Reversibility of heterotopic proliferative glands in glandular stomac Helocobacter pylori infected Mongolian gerbil on eradication."Jpn J Cancer Res. 93. 374-381 (2002)
Nozaki K、Shimizu N、Tsukamoto T、Sugiyama A 等人:“根除感染蒙古沙鼠的腺胃异位增殖腺的可逆性。”Jpn J Cancer Res。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Gotoh A, Akamatsu T, Shimizu T, Sugiyama A et al.: "Addititive effect of pronase on the efficiacy of eradication therapy against Helicobacter pylori."Hericobacter. 7. 183-191 (2002)
Gotoh A、Akamatsu T、Shimizu T、Sugiyama A 等人:“链霉蛋白酶对幽门螺杆菌根除治疗效果的累加效应。”幽门螺杆菌。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SUGIYAMA Atsushi其他文献

SUGIYAMA Atsushi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SUGIYAMA Atsushi', 18)}}的其他基金

Effects of EP4 receptor agonist on the left ventricular diastolic function, and analysis of its mechanism
EP4受体激动剂对左心室舒张功能的影响及其机制分析
  • 批准号:
    16K08559
  • 财政年份:
    2016
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of onset mechanisms of a sphingosine 1-phosphate receptor modulator fingolomod-induced atrioventricular conduction block
1-磷酸鞘氨醇受体调节剂芬戈洛莫德引起房室传导阻滞的发病机制分析
  • 批准号:
    25460344
  • 财政年份:
    2013
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of therapeutic target molecules againstatrial fibrillation: Use of the canine persistent atrial fibrillation model
抗房颤治疗靶分子的鉴定:犬持续性房颤模型的使用
  • 批准号:
    22590237
  • 财政年份:
    2010
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Search of upstream drugs for treatment of atrial fibrillation using a new canine atrial fibrillation model
利用新的犬房颤模型寻找治疗房颤的上游药物
  • 批准号:
    17590216
  • 财政年份:
    2005
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Dangerous QT prolongation can be assayed by using the chronic atrioventricular block dog
可以使用慢性房室传导阻滞犬来检测危险的 QT 延长
  • 批准号:
    15590222
  • 财政年份:
    2003
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Experimental and Clinical Studied for process of gastric carcinogenesis
胃癌发生过程的实验与临床研究
  • 批准号:
    12671215
  • 财政年份:
    2000
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Attempt to stratify gastric cancer patients by AI using general clinical information
尝试利用一般临床信息通过人工智能对胃癌患者进行分层
  • 批准号:
    23K08102
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
stablishment of non-invasive DNA methylation panel for peritoneal metastasis of gastric cancer patients
胃癌腹膜转移非侵入性DNA甲基化检测试剂盒的建立
  • 批准号:
    23K08210
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development a novel immnunotherapy for gastric cancer by targeted SMARCA4
通过靶向 SMARCA4 开发一种新型胃癌免疫疗法
  • 批准号:
    23K15047
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Prospective metabolomics investigation of gastric cancer risk in African Americans and European Whites with a low socioeconomic status
社会经济地位较低的非裔美国人和欧洲白人胃癌风险的前瞻性代谢组学调查
  • 批准号:
    10912190
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
The clinical impact of drug holiday in treatment of metastatic gastric cancer
药物假期对转移性胃癌治疗的临床影响
  • 批准号:
    23K09533
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of Gastric Cancer Therapy Targeting Pyruvate Metabolism
针对丙酮酸代谢的胃癌治疗的进展
  • 批准号:
    22KJ1826
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Computational imaging approaches to personalized gastric cancer treatment
个性化胃癌治疗的计算成像方法
  • 批准号:
    10585301
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Effect of ant-claudin antibody against peritoneal metastasis from gastric cancer
抗密蛋白抗体对抗胃癌腹膜转移的作用
  • 批准号:
    23K19642
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Development of a Novel Cancer Therapy Strategy Targeting TGFBI in Gastric Cancer Stroma
开发针对胃癌基质中 TGFBI 的新型癌症治疗策略
  • 批准号:
    23K15513
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Exosomal microRNAs in peritoneal fluid of gastric cancer patients with peritoneal metastasis induce drug resistance
胃癌腹膜转移患者腹腔液中的外泌体microRNA诱导耐药
  • 批准号:
    23K14650
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了